epidemiology of noncardiac surgery

29
Epidemiology of Noncardiac Surgery Dr. Mohammed Naser

Upload: major

Post on 06-Feb-2016

67 views

Category:

Documents


0 download

DESCRIPTION

Epidemiology of Noncardiac Surgery. Dr. Mohammed Naser. Overview. Important Decision points: Urgent vs Elective Surgery High risk surgery vs intermediate vs low -Active Cardiac Condition vs non-active Functional capacity on basis of pt ablility To perform certain activities. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Epidemiology of  Noncardiac Surgery

Epidemiology of Noncardiac Surgery

Dr. Mohammed Naser

Page 2: Epidemiology of  Noncardiac Surgery
Page 3: Epidemiology of  Noncardiac Surgery

Overview

• Important Decision points:– Urgent vs Elective Surgery– High risk surgery vs intermediate vs low

-Active Cardiac Condition vs non-active

Functional capacity on basis of pt ablility

To perform certain activities

Page 4: Epidemiology of  Noncardiac Surgery

The Search For High Risk

Page 5: Epidemiology of  Noncardiac Surgery

Methods for Assessing Risk Pre-Operatively

Is the surgery emergency

PROCEED and manage post operatively

according to AHA& ACC guidelines

Page 6: Epidemiology of  Noncardiac Surgery

If the surgery emergency..??

Page 7: Epidemiology of  Noncardiac Surgery

Active/Major Cardiac Conditions

• Unstable Coronary Conditions

• Decompensated CHF

• Significant arrhythmias (i.e. 3 HB, new ⁰Vtach)

• Severe Valvular Disease (aortic stenosis >40 mm hg gradient or valve area <1.0cm₂)???????

Page 8: Epidemiology of  Noncardiac Surgery

Non-Active Cardiac Factors

• Intermediate Risk • Hx of CHD• History of prior

CHF• Hx of stroke• Diabetes • Renal insufficiency

• Minor Risk*• Age > 70• Abnormal ECG• Nonsinus rhythm• Uncontrolled

systolic BP

* Not associated with cardiac risk

Page 9: Epidemiology of  Noncardiac Surgery

Six Independent predictors of cardiac risk

1) ischemic heart disease

2) congestive heart failure

3) cerebrovascular disease

4) high risk surgery (AAA, orthopedic sx)

5) pre-operative insulin tx for diabetes

6) preoperative creatinine for creat > 2 mg/dL

Lee et al

Page 10: Epidemiology of  Noncardiac Surgery

Functional capacity

Page 11: Epidemiology of  Noncardiac Surgery

Functional Capacity

• Functional status has shown to be a reliable periop and long-term predictor of cardiac events

• MET: metabolic equivalent resting oxygen consumption of 70 kg, 40 yr old man at rest

• Periop risk is increased if person cannot > 4 METS

Page 12: Epidemiology of  Noncardiac Surgery

1 MET 4 MET 10 MET

Eat, d

ress

DO li

ght h

ouse

wor

k i.e.

Was

hing d

ishes

Climb a

fligh

t of s

tairs

Run a sh

ort d

istan

ces

Mod

erat

e rec

reat

iona

l gol

f, da

ncin

g, b

aseb

all

Stre

nuou

s spo

rts s

wimm

ing,

bas

ketb

all

Page 13: Epidemiology of  Noncardiac Surgery

The Trump Card: Functional Capacity

• Perioperative cardiac risk is increased in patients unable to exercise 4 METs

• Functional capacity can be estimated in the office

– Energy expenditure for eating, dressing, walking around house, dishwashing ranges from 1-4 METs

– Climbing a flight of stairs, running a short distance, scrubbing floors, and golf ranges from 4-10 METs

– Swimming and singles tennis exceeds 10 METs

Page 14: Epidemiology of  Noncardiac Surgery

Surgery Risk Type

Type Cardiac risk examples

High > 5% Aortic, peripheral vasc sx

Intermediate risk 1-5% IntraperitonealIntrathoracicCarotid EndHead and neckOrthopedic SxProstate Sx

Low <1% Endoscopic proceduresSuperficialCataract SxBreast SxAmbulatory Sx

Page 15: Epidemiology of  Noncardiac Surgery

Surgery-Specific Risk: High Risk*

• Major emergency surgery

• Vascular surgery including: aortic surgery, infra-inguinal bypass

• Prolonged surgery with large fluid shifts or blood loss

* Reported risk of cardiac death or nonfatal MI >5%

Page 16: Epidemiology of  Noncardiac Surgery

Stepwise Approach

• Step 1: Determine urgency of surgery

• Step 2: Active cardiac condition?-→test

• Step 3: Undergoing low-risk surgery? < 1%*

• Step 4: Good functional capacity?

* Combined morbidity and mortality < 1% even in high risk

patients

Page 17: Epidemiology of  Noncardiac Surgery

The Catheterization Questions to Ask Yourself

• Does this patient have symptomatic coronary disease that will have a mortality benefit from revascularization now?

• Am I willing to send the patient to CABG?

• Am I doing this just to know the anatomy?

Page 18: Epidemiology of  Noncardiac Surgery

Is pre-op coronary revasc advantageous?

• If high risk surgery and patient has active cardiac issue

• Functional test and perfusion Imaging and if

• L main 50% or 3 VD, 2VD + LAD Prox, LVEF < 20%, aortic stenosis – consider revasc pre-op

Page 19: Epidemiology of  Noncardiac Surgery

STENTS

If upcoming Sx is known then PTCA alone or BMS with 4-6 wks dual antiplatelet tx after

If received DES....– 1) postpone sx until > 12 months,– 2) do sx on both asa+clop – 3) do sx on single ap tx

Page 20: Epidemiology of  Noncardiac Surgery

Use of a DES for coronary revascularization before imminent or planned non cardiac sx that will necessitate d/c of antiplatelet agents is not recommended

Page 21: Epidemiology of  Noncardiac Surgery

Medical tx

1) beta blockers-if on keep them if not....

2) Statins continue, ? Start -need randomized trials

Page 22: Epidemiology of  Noncardiac Surgery

Other Issues

• DVT/PE prophylaxis

• Anesthetic technique-volatile agent with general anesthetic - ↓ troponin ↑ LV function >> propofol, midazolam, balanced anesthesia (Grade B)

• No evidence that epidural anesthesia >>general anesthesia for cardiac outcomes

• Routine troponin monitoring not recommended

Page 23: Epidemiology of  Noncardiac Surgery

Surveillance for Perioperative Myocardial Infarction

• ECGs–All intermediate and high-risk patients

should get a post-op ECG.–As need for signs or symptoms of

ischemia

• Troponin / CK – In patients with signs or symptoms of

ischemia–Do not do screening biomarkers

Page 24: Epidemiology of  Noncardiac Surgery

High Risk Features

• Severe obstructive or restrictive pulmonary disease

• Diabetes

• Renal impairment

• Anemia, polycythemia, thrombocytosis

Page 25: Epidemiology of  Noncardiac Surgery

PCI pre-op

• ST-elevation MI

• Unstable angina

• Non ST elevation MI

Page 26: Epidemiology of  Noncardiac Surgery

2007 ACC/AHA Perioperative Guidelines

Page 27: Epidemiology of  Noncardiac Surgery

Take Home Messages

Page 28: Epidemiology of  Noncardiac Surgery

Take Home Messages• Unstable syndromes require management prior to surgery. Look

for

– Unstable angina

– Signs of heart failure

– Stenotic valve lesions

– Ventricular arrhythmias

• Functional tolerance is the best single predictor of outcome

• Be very specific in your history (one step at at time, regular or slow pace, etc)

• If patient on beta blockers & statins continue them, more trials to mandate them

• PCI/CABG only if patient needs it independent of surgery. Think twice because of stent data and delays.

Page 29: Epidemiology of  Noncardiac Surgery